首页> 外文会议>World biomaterials congress >Bone augmentation in sinus floor elevation by octacalcium phosphate collagen composite
【24h】

Bone augmentation in sinus floor elevation by octacalcium phosphate collagen composite

机译:磷酸八钙胶原蛋白复合物可增加窦底高位

获取原文

摘要

Introduction: Synthetic octacalcium phosphate (OCP) has become recognized as a highly osteoconductive bone substitute material based on in vitro and vivo studies . OCP enhances osteoblastic cell differentiation in vitro in a dose-dependent manner . Furthermore, the dose-dependent stimulatory capacity of OCP was confirmed in vivo implantation with collagen matrix in rat critical sized calvaria defect W. OCP has higher solubility than be-ta tricalcium phosphate (be-ta TCP) therefore more resorbable than beta TCP in vivo . It has been shown that OCP combined with collagen (OCP/Collagen) facilitates bone regeneration in comparison with OCP itself . The osteoconductivity of OCP/Collagen has been demonstrated also in critical-sized bone defect of dog . After that, we examined the effect of OCP/Collagen on bone regeneration in human small bone defect and confirmed the healing at the defect. In this study, we performed sinus floor elevation for bone augmentation by OCP/Collagen as a preparation for dental implant treatment in clinical patient. Experimental methods: OCP was prepared according to a method of synthesis by mixing calcium nad phosphate solution . Particle size of OCP was 300 - 500 micrometer in diameter. OCP/Collagen was molded in the shape of a disc, 9 mm diameter, and 1.5 mm thick. Then OCP/Collagen was sterilized using electron beam irradiation at 15kGy. The protocol of the clinical trial was submitted and approved by the research ethics commitee of the Tohoku University Graduate School of Dentistry. In this study, we performed sinus floor elevation in a 41-years old man at left sinus under local anesthesia. 19 OCP/Collagen discs (approximately 1.8 cc) were used in this surgery. We observed the healing at operative region and confirmed having infection or allergy, or not and radiographic examination or CT scan was performed at 3 or 6 months after operation. Furthermore, we performed bone biopsy at the same time of placement of dental implant and we examined the newly formed bone historically. Result: There was no abnormality for healing, no infection and no allergic reaction for the entire period. OCP or OCP/Collagen does not have radiopacity under normal X-ray condition. However, radiopacity of OCP/Collagen implanted in sinus increased with time. CT scan showed radiopacity at 3 months after implantation. At 6 months, the radiopacity of that was almost same as surrounding bone of that in cancellous bone. Histological analysis showed the normal bone tissue including a little remaining impants. Discussion: These results showed that OCP/Collagen could convert to bone tissue in clinical use of sinus floor elevation. It was suggested that OCP/Collagen could be a suitable material for bone augmentation.
机译:简介:根据体外和体内研究,合成的磷酸八钙(OCP)已被公认为具有高骨传导性的骨替代材料。 OCP以剂量依赖的方式增强体外成骨细胞的分化。此外,在大鼠临界大小的颅骨缺损W中用胶原蛋白基质体内植入证实了OCP的剂量依赖性刺激能力。OCP的溶解度高于β-磷酸三钙(be-ta TCP),因此比β-TCP在体内更易吸收。已经显示,与OCP本身相比,OCP与胶原蛋白(OCP /胶原蛋白)的结合促进了骨再生。 OCP /胶原蛋白的骨传导性也已在狗的临界骨缺损中得到证实。此后,我们检查了OCP /胶原蛋白对人小骨缺损中骨再生的影响,并确认了缺损处的愈合。在这项研究中,我们通过OCP /胶原蛋白进行了窦底抬高以增加骨质,为临床患者的牙科植入物治疗做准备。实验方法:通过混合磷酸钠和磷酸钙溶液根据合成方法制备OCP。 OCP的粒径为直径300-500微米。 OCP /胶原蛋白被模制成圆盘状,直径为9毫米,厚度为1.5毫米。然后使用15kGy的电子束辐照对OCP /胶原进行灭菌。东北大学牙科研究生院的研究伦理委员会已提交并批准了该临床试验的方案。在这项研究中,我们在一名左鼻窦局部麻醉的41岁男性中进行了鼻窦底抬高。该手术中使用了19个OCP /胶原蛋白光盘(约1.8 cc)。我们观察了手术部位的愈合情况,确认是否感染或过敏,并在术后3或6个月进行了放射线检查或CT扫描。此外,我们在放置牙科植入物的同时进行了骨活检,并历史性地检查了新形成的骨。结果:在整个过程中,没有愈合异常,没有感染,也没有过敏反应。在正常的X射线条件下,OCP或OCP /胶原蛋白不具有射线不透性。然而,植入窦内的OCP /胶原蛋白的不透射线性随时间增加。 CT扫描显示植入后3个月的射线不透性。在6个月时,其射线不透性几乎与松质骨中的周围骨相同。组织学分析显示正常的骨组织包括少量残留物。讨论:这些结果表明,OCP /胶原蛋白可在临床上将窦底高位转化为骨组织。有人提出,OCP /胶原蛋白可能是一种适合骨骼增强的材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号